Roger D Cone
Research Professor
Email:
[email protected]
Available to mentor
Roger D Cone
Research Professor
Manage Your Profile
Center Memberships
-
Center MemberCaswell Diabetes Institute
Recent Publications
-
Li L, Hernandez CC, Gimenez LE, Xu B, Dahir NS, Peisley A, Wu Z, Chen M, Serrato A, Wan R, Swati , Birnbaum SG, Cone RD, Liu C. Nature Communications, 2026 Dec 1; 17 (1):Journal ArticleFunctional coupling between MC4R and Kir7.1 contributes to clozapine-induced weight gain in female mice
DOI:10.1038/s41467-026-76561-w PMID: 42693128 -
Peisley A. Nature Communications, 2026 Jul 2;Journal ArticleStructural and Functional Studies of Inward Rectifier Kir7.1 and its Regulation by the Melanocortin-4 Receptor
-
Buscaglia P, Bowman KR, Lawler K, Hernandez CC, Scotucci J, Bounds R, Keogh JM, Henning E, Cone RD, Farooqi IS, Sebag JA. Nature Communications, 2026 Sep 23;Journal ArticleAttractin-like protein 1 is an essential partner of MC4R to regulate body weight
DOI:10.1038/s41467-026-77897-z -
Buscaglia P, Bowman KR, Lawler K, Hernandez CC, Scotucci J, Bounds R, Keogh JM, Henning E, Cone RD, Farooqi IS, Sebag JA. 2026 Jan 19; medRxiv,PreprintAttractin-Like Protein 1 (ATRNL1): An Essential Partner of MC4R to Regulate Body Weight
DOI:10.64898/2026.01.12.26343722 -
Danjo ND, da Silva AC, Cone RD. Journal of the Endocrine Society, 2025 Oct 24; 9 (Supplement_1): bvaf149.017Journal ArticleMON-677 Role Of The Melanocortin-3 Receptor In Regulation Of Lean Mass, Muscle Function, And Exercise-induced Hyperphagia
DOI:10.1210/jendso/bvaf149.017 PMID: PMC12544962 -
Caruso V, Tatro JB, Schiöth H, Pouton C, Mountjoy KG, Hruby VJ, Haskell-Luevano C, Gantz I, Fong TM, Farooqi S, Eberle AN, Cone RD, Clark AJL, Chai B-X, Wikberg JES. IUPHAR/BPS Guide to Pharmacology CITE, 2025 Oct 20; 2025 (3):Journal ArticleMelanocortin receptors in GtoPdb v.2025.3
DOI:10.2218/gtopdb/f38/2025.3 -
Joy ST, Dahir NS, Cone RD, Mapp AK. Peptide Science, 2025 Jan 1; 117 (1):Journal ArticleAn Improved Synthesis of Compound 11, a Unique Bicyclic Melanocortin-3 Antagonist
DOI:10.1002/pep2.24385 -
Lu ZA, Ploner A, Birgegård A, Adan R, Alfredsson L, Ando T, Andreassen O, Baker J, Bergen A, Berrettini W, Boden J, Boehm I, Perica VB, Brandt H, Breen G, Bryois J, Buehren K, Bulik C, Burghardt R, Cassina M, Cichon S, Coleman J, Cone R, Courtet P, Crawford S, Crow S, Crowley J, Danner U, Davis O, De Zwaan M, Dedoussis G, Desocio J, Dick D, Dikeos D, Dina C, Dmitrzak-Weglarz M, Docampo E, Duncan L, Egberts K, Ehrlich S, Escaramís G, Esko T, Estivill X, Farmer A, Favaro A, Fernández-Aranda F, Fischer K, Föcker M, Foretova L, Forstner A, Forzan M, Franklin C, Gallinger S, Giegling I, Giusti-Rodríguez P, Gonidakis F, Gordon S, Gorwood P, Mayora MG, Grove J, Guillaume S, Guo Y, Hakonarson H, Halmi K, Hanscombe K, Hatzikotoulas K, Hauser J, Hebebrand J, Helder S, Herms S, Herpertz-Dahlmann B, Herzog W, Hinney A, Horwood LJ, Hübel C, Huckins L, Hudson J, Imgart H, Inoko H, Janout V, Jiménez-Murcia S, Johnson C, Jordan J, Julià A, Kalsi G, Kaminská D, Kaplan A, Kaprio J, Karhunen L, Karwautz A, Kas M, Kaye W, Kennedy J, Kennedy M, Keski-Rahkonen A, Kiezebrink K, Kim YR, Klareskog L, Klump K. Schizophrenia Bulletin, 2024 Sep 1; 50 (5): 1255 - 1265.Journal ArticleShared Genetic Architecture Between Schizophrenia and Anorexia Nervosa: A Cross-trait Genome-Wide Analysis
DOI:10.1093/schbul/sbae087 PMID: 38848516
Featured News & Stories
Health Lab
Protein targets can act as a switch for obesity and anorexia
In the U.S., dietary obesity has a prevalence of 40% and obesity increases the risk of other chronic diseases such as heart disease and diabetes. Even though anorexia nervosa has a prevalence of 1%, it is the second-highest death rate of any mental illness. Roger Cone discusses how melanocortin receptors can be used to treat both obesity and anorexia.
Health Lab
Diabetes and weight loss drugs could be enhanced, shows study in mice
A network of proteins found in the central nervous system could be harnessed to increase the effectiveness, and reduce the side effects, of diabetes and weight-loss drugs such as Ozempic and Mounjaro, according to research from the University of Michigan Life Sciences Institute.
Points of Blue
Katie Emery, PhD Candidate: Staying intentional in and out of the lab
Katie Emery is a PhD Candidate in the Neuroscience Graduate Program.